Get more info on this report!Minimally Invasive Surgical Devices, World MarketMay 1, 2011Mini...
this report are laryngoscopes, ventriculoscopes, contact lasers, others)   •   Cardiovascular MIS Device Market (included ...
•   ProstatectomyThe information for this report was gathered using both primary and secondary researchincluding comprehen...
bloodstream infections, a 59% reduction in wound infections and a 39% reduction inurinary tract infections."Reducing hospi...
The 2011-2016 World Outlook for Antacids by Icon Group International, Inc.This econometric study covers the world outlook ...
Hand Instruments    Electrosurgical and Radiofrequency Instruments    Insufflators    Power Surgical Instruments    Lasers...
Technology Integration     MIS Solution     Materials Industry Concerns     Hospital- Acquired Infection     New Treatment...
Introduction    Procedure Volumes    Products    Market Size and Forecast    Market Analysis by Country    Leading Competi...
CHAPTER ELEVEN: CONCLUSIONSCHAPTER TWELVE: CORPORATE PROFILES     Overview     Aesculap Division     ArthroCare Inc     Bo...
Table 2-2: Estimated World Population by Age and Geographical Region, 2010    Figure 2-2: Estimated World Population by Ag...
Figure 6-2: MIS: ENT and Respiratory Market Analysis: 2008-2015    Table 6-4: MIS: ENT and Respiratory Market Analysis by ...
Figure 9-1: U.S. and Europe Procedure Volumes for Urological and    Gynecological*    Table 9-2: MIS: Urological and Gynec...
Figure 10-8: Total Minimally Invasive Surgery Estimated Market Share by       Leading Suppliers 2010CORPORATE PROFILES    ...
Upcoming SlideShare
Loading in …5
×

Minimally Invasive Surgical Devices, World Market

1,129 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,129
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
21
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Minimally Invasive Surgical Devices, World Market

  1. 1.    Get more info on this report!Minimally Invasive Surgical Devices, World MarketMay 1, 2011Minimally invasive surgery (MIS) allows doctors to perform many complicatedoperations with a short hospital stay. It is a safe, feasible, and patient-friendly method ofperforming an operation. Major trends show MIS has been shown to reduce hospital-acquired infections.The report includes product information, procedure volume data, world demographics;and other general issues affecting the MIS device market. Information is presented as aworldwide overview, with a focus on the US. A market summary includes marketanalysis by intended use and a competitive analysis of leading providers. Additionallykey company profiles are included. The following companies are profiled in this report: • Aesculap Division • ArthroCare Inc • Boston Scientific Corporation • Conmed Corporation • Covidien Ltd • Given Imaging, Ltd. • Innovative Surgical Inc. • Johnson & Johnson, Inc • Karl Storz GmbH & Co. KG • Medtronic, Inc • Olympus Corporation • Smith & Nephew, Plc • Stryker CorporationThe report provides total market sizes in six general surgery areas reflecting revenuesearned by all manufacturers in all MIS methods in those areas. Revenues for eachtherapeutic area were gathered through both primary and secondary research methods.General surgery areas include: • Orthopedic MIS Device Market (included in total market size number in this report are arthoscopes, autoclavable laoparoscope, holmium lasers, other devices) • Neurosurgery MIS Device Market (included in total market size number in this report are neuroendoscopes, bronchoscope, esophoscope, others) • ENT/Respiratory MIS Device Market (included in total market size number in
  2. 2. this report are laryngoscopes, ventriculoscopes, contact lasers, others) • Cardiovascular MIS Device Market (included in total market size figure are laparoscopes, ablation systems, endoscopes, others) • Gastrointestinal System MIS Device Market (included in total market size figure are endoscopes, sigmoidoscopes, videoscopes, others) • Urological and Gynecological MIS Device Market (included in total market size figure are hysteroscopes, cystoscopes, others)The purpose of this report is to provide understanding of the total current market for allMIS methods for each therapeutic area. In the scope of this report they are consideredas competitive methods and are not broken down to specific device segments (forinstance Gastroinestinal System Devices will contain a number for all competiting MISmethods in GI, but will not have a specific sigmoidoscope or GI endoscope number.)Five year forecasts are also provided. As this is a global survey, Revenues are providedfor the following regions: • US • Europe • Rest of WorldProcedure volumes are available for the following surgeries for which minimally invasiveequipment is utilized: • Hip Replacement, Pinning, etc. • Knee Repair/Fixation, Procedures • Spinal Fusion/Spinal Hardware Removal • Shoulder Repair/Fixation • Lumbar Laminectomy/ Thoracic-lumbar • Laminectomy/Diskectomy and Lumbar Decompression and Fusion • Craniotomy (all types) • Ventricular-Peritoneal Shunt Insertion/ Removal/Revision • Detether Cord (adult and pediatric) • Ethmoidectomy • Tonsillectomy • Thyroidectomy • Coronary Revascularization • Aortic Valve Replacement or Repair • Cardiac Catheterization • Insertion of Coronary Artery Stent(s) • Appendectomy • Endoscopy with or without biopsy • Cholecystectomy • Inguinal Herniorrhaphy • Hysterectomy (all types)
  3. 3. • ProstatectomyThe information for this report was gathered using both primary and secondary researchincluding comprehensive research of secondary sources such as company literature,databases, investment reports, and medical and business journals. Telephoneinterviews and email correspondence were the primary method of gathering information.For the purpose of this study, Kalorama Information conducted interviews with morethan 45 key industry officials, consultants, health care providers, and governmentpersonnel. These sources were the primary basis in gathering information specificallyrelating to revenue and market share data presented in this report. Additional interviewswere completed with relevant company representatives including marketing directors,division managers, and product representatives:All market data pertains to the world market at the manufacturers’ level. The base yearfor data was 2010. Compound annual growth rates (CAGRs) are provided for eachregion and/or segment covered. Competitive analysis is provided for the year 2010. Theforecasted market analysis for was largely based on demographic trends, newdevelopments, and global expansion.Additional InformationNew York, NY, May 11, 2011-Data that shows minimally invasive surgery (MIS)procedures may reduce hospital-acquired infections will give an additional boost to the$24.8 billion market for MIS equipment, according to healthcare market research firmKalorama Information. Kalorama estimates this market will reach $34.8 billion by 2015in its latest report, Minimally Invasive Surgical Devices, World Market.Minimally invasive surgery, which uses specialized instruments, miniature cameras withmicroscopes, tiny fiber-optic flashlights and high definition monitors, makes an incisionabout 2 to 4 inches in length, which is much smaller than the traditional 6 to 10 inches.The report cites recent survey data which found that using this method results in lesstrauma to the body, less blood loss, smaller surgical scars, a lower risk of contracting ahospital-acquired infection and shorter hospital stays."Its a win-win for government and insurance companies looking to reduce long-termhealthcare costs," says Bruce Carlson, publisher of Kalorama Information. "Although thedevices are expensive, the cost is justified by long-term savings and more effectivepatient treatment."According to the report, 40% of hospital-acquired infections from hysterectomy,appendectomy and laparoscopic cholecystectomy occurred within 30 days after hospitaldischarge. However, the use of MIS saw an overall decrease in the odds of acquiring aninfection, specifically an 80% reduction in respiratory tract infections, a 69% reduction in
  4. 4. bloodstream infections, a 59% reduction in wound infections and a 39% reduction inurinary tract infections."Reducing hospital-acquired infections translates to a reduction in readmissions to thehospital, patient suffering and cost," adds Carlson. "The key factor in the use of thesedevices is keeping patients in the hospital for the least amount of time."Minimally Invasive Surgical Devices, World Market includes product information,procedure volume data, world demographics and trends, as well as detailed companyprofiles. Total market sizes for six general surgery areas, reflecting revenue earned bymanufacturers, are broken up by U.S., Europe and Rest of World.More Gastrointestinal Reports by Kalorama InformationClinical Nutrition Products, 4th Edition by Kalorama InformationThis Kalorama Information report - Clinical Nutrition - focuses on three primarysegments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based,Special Needs such as ...The World Market for Gastrointestinal Endoscopy Equipment by Kalorama InformationThe gastrointestinal endoscopy market is a market on the rise. With continuallyadvancing technologies available and world population increasing every year, thegastrointestinal endoscopy market. ...The World Market for Prescription Gastrointestinal Drugs by Kalorama InformationThis report provides and in-depth analysis of the market for prescription drugs used inthe treatment of gastrointestinal (GI) disorders, such as nausea and vomiting, ...The U.S. Market for Over-the-Counter Gastrointestinal Products, 2nd Edition byKalorama InformationThe market for OTC Gastrointestinal products has gone through several significantchanges in the past 5 years, most of which have to do with the ...The U.S. Market for OTC Gastrointestinal Products by Kalorama InformationThe US Market for OTC Gastrointestinal Products is a comprehensive analysis of theimpact OTC drugs have made to the gastrointestinal market. This study ...More Global Gastrointestinal ReportsThe 2011-2016 World Outlook for Irritant Laxative Pharmaceutical Preparations by IconGroup International, Inc.This econometric study covers the world outlook for irritant laxative pharmaceuticalpreparations across more than 200 countries. For each year reported, estimates aregiven for ...
  5. 5. The 2011-2016 World Outlook for Antacids by Icon Group International, Inc.This econometric study covers the world outlook for antacids across more than 200countries. For each year reported, estimates are given for the latent demand, ...The 2011-2016 World Outlook for Antacid Pharmaceutical Preparations ExcludingEffervescent Salicylate Analgesics by Icon Group International, Inc.This econometric study covers the world outlook for antacid pharmaceuticalpreparations excluding effervescent salicylate analgesics across more than 200countries. For each year reported, estimates ...Peptic Ulcer Global Clinical Trials Review, Q4, 2010 by GlobalDataPeptic Ulcer Global Clinical Trials Review, Q4, 2010 Summary GlobalDatas clinical trialreport, “Peptic ulcer Global Clinical Trials Review, Q4, 2010"" provides data ...Disease and Therapy Review: Irritable Bowel Syndrome by Timely Data Resources, Inc.The Irritable Bowel Syndrome Disease and Therapy Review provides an overview of thecondition, with prevalence numbers for major countries worldwide, information ondiagnosis, and ...TABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Size and Growth of the Market Key Issues and Trends Affecting the Market Leading CompetitorsCHAPTER TWO: INTRODUCTION Overview World Demographics Description of MIS Procedures Product Categories Endoscopes Cameras and Video Support
  6. 6. Hand Instruments Electrosurgical and Radiofrequency Instruments Insufflators Power Surgical Instruments Lasers Other (disposables) Distribution, Sales and Marketing Medical Applications Orthopedic Neurosurgery Ear, Nose, and Throat and Respiratory Cardiovascular Gastrointestinal System Urological and Gynecological Advantages of Minimally Invasive Surgery Disadvantages of Minimally Invasive SurgeryCHAPTER THREE: ISSUES AND TRENDS Overview Training and Education Cost and Reimbursement Natural Orifice Translumenal Endoscopic Surgery Single Port Laparoscopic Surgery Obesity Robotics and MIS Global Opportunities Shifting Centers Haptics Technology
  7. 7. Technology Integration MIS Solution Materials Industry Concerns Hospital- Acquired Infection New Treatment MarketsCHAPTER FOUR: ORTHOPEDIC MIS Introduction Procedure Volumes Products Market Size and Forecast Market Analysis by Country Leading CompetitorsCHAPTER FIVE: NEUROSURGERY MIS Introduction Procedure Volumes Products Market Size and Forecast Market Analysis by Country Leading CompetitorsCHAPTER SIX: ENT AND RESPIRATORY MIS Introduction Procedure Volumes Products Market Size and Forecast Market Analysis by Country Leading CompetitorsCHAPTER SEVEN: CARDIOVASCULAR MIS
  8. 8. Introduction Procedure Volumes Products Market Size and Forecast Market Analysis by Country Leading CompetitorsCHAPTER EIGHT GASTROINTESTINAL SYSTEM MIS Introduction Procedure Volumes Products Market Size and Forecast Market Analysis by Country Leading CompetitorsCHAPTER NINE: UROLOGICAL AND GYNECOLOGICAL MIS Introduction Procedure Volumes Products Market Size and Forecast Market Analysis by Country Leading CompetitorsCHAPTER TEN: TOTAL MARKET SIZE AND FORECAST Total Market Overview Minimally Invasive Surgery Market by Application U.S. Market Size Europe Market Size Rest of World Market Size Leading Competitors
  9. 9. CHAPTER ELEVEN: CONCLUSIONSCHAPTER TWELVE: CORPORATE PROFILES Overview Aesculap Division ArthroCare Inc Boston Scientific Corporation Conmed Corporation Covidien Ltd Given Imaging, Ltd. Innovative Surgical Inc. Johnson & Johnson, Inc Karl Storz GmbH & Co. KG Medtronic, Inc Olympus Corporation Smith & Nephew, Plc Stryker CorporationLIST OF MAJOR COMPANIESLIST OF EXHIBITSTABLE OF CONTENTSLIST OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARY Summary Table: MIS: Total Market Analysis, 2008-2010 Summary Table: MIS: Total Market Analysis: 2011-2015 Figure 1-1: Minimally Invasive Surgery: Total Market Analysis: 2008-2015CHAPTER TWO: INTRODUCTION Table 2-1: World Population by Selected Geographical Region, 2010 - 2050 Figure 2-1: World Population by Selected Geographical Region, 2010-2050
  10. 10. Table 2-2: Estimated World Population by Age and Geographical Region, 2010 Figure 2-2: Estimated World Population by Age and Geographical Region, 2010CHAPTER THREE: ISSUES AND TRENDS Table 3-1CHAPTER FOUR: ORTHOPEDIC Table 4-1: U.S. and Europe Procedure Volumes for Orthopedic Surgery* Figure 4-1: U.S. and Europe Procedure Volumes for Orthopedic Surgery* Table 4-2: MIS: Orthopedic Market Analysis, 2008-2010 Table 4-3: MIS: Orthopedic Market Analysis: 2011-2015 Figure 4-2: MIS: Orthopedic Market Analysis: 2008-2015 Table 4-4: MIS: Orthopedic Market Analysis by Region/Country, 2010 Figure 4-3: MIS: Orthopedic Market Analysis by Region/Country, 2010 Table 4-5: Leading MIS Orthopedic Instrument and Equipment Suppliers, 2010CHAPTER FIVE: NEUROSURGERY Table 5-1: U.S. and Europe Procedure Volumes for Neurosurgery* Figure 5-1: U.S. and Europe Procedure Volumes for Neurosurgery Table 5-2: MIS: Neurosurgery Market Analysis, 2008-2010 Table 5-3: MIS: Neurosurgery Market Analysis: 2011-2015 Figure 5-2: MIS: Neurosurgery Market Analysis: 2008-2015 Table 5-4: MIS: Neurosurgery Market Analysis by Region/Country, 2010 Figure 5-3: MIS: Neurosurgery Market Analysis by Region/Country, 2010 Table 5-5: Leading MIS Neurosurgery Instrument and Equipment Suppliers, 2010CHAPTER SIX: ENT AND RESPIRATORY Table 6-1: U.S. and Europe Procedure Volumes for ENT/Respiratory* Figure 6-1: U.S. and Europe Procedure Volumes for ENT and Respiratory* Table 6-2: MIS: ENT and Respiratory Market Analysis, 2008-2010 Table 6-3: MIS: ENT and Respiratory Market Analysis: 2011-2015
  11. 11. Figure 6-2: MIS: ENT and Respiratory Market Analysis: 2008-2015 Table 6-4: MIS: ENT and Respiratory Market Analysis by Region/Country, 2010 Figure 6-3: MIS: ENT and Respiratory Market Analysis by Region/Country, 2010 Table 6-5: Leading MIS ENT and Respiratory Instrument and Equipment Suppliers, 2010CHAPTER SEVEN: CARDIOVASCULAR Table 7-1: U.S. and Europe Procedure Volumes for Cardiovascular Surgery* Figure 7-1: U.S. and Europe Procedure Volumes for Cardiovascular Surgery* Table 7-2: MIS: Cardiovascular Market Analysis, 2008-2010 Table 7-3: MIS: Cardiovascular Market Analysis: 2011-2015 Figure 7-2: MIS: Cardiovascular Market Analysis: 2008-2015 Table 7-4: MIS: Cardiovascular Market Analysis by Region/Country, 2010 Figure 7-3: MIS: Cardiovascular Market Analysis by Region/Country, 2010 Table 7-5: Leading MIS Cardiovascular Instrument and Equipment Suppliers, 2010CHAPTER EIGHT: GASTROINTESTINAL SYSTEM Table 8-1: U.S. and Europe Procedure Volumes for Gastrointestinal System* Figure 8-1: U.S. and Europe Procedure Volumes for Gastrointestinal System* Table 8-2: MIS: Gastrointestinal System Market Analysis, 2008-2010 Table 8-3: MIS: Gastrointestinal System Market Analysis: 2011-2015 Figure 8-2: MIS: Gastrointestinal System Market Analysis: 2008-2015 Table 8-4: MIS: Gastrointestinal System Market Analysis by Region/Country, 2010 Figure 8-3: MIS: Gastrointestinal System Market Analysis by Region/Country, 2010 Table 8-5: Leading MIS Gastrointestinal System Instrument and Equipment Suppliers, 2010CHAPTER NINE: UROLOGICAL AND GYNECOLOGICAL Table 9-1: U.S. and Europe Procedure Volumes for Urological and Gynecological*
  12. 12. Figure 9-1: U.S. and Europe Procedure Volumes for Urological and Gynecological* Table 9-2: MIS: Urological and Gynecological Market Analysis, 2008-2010 Table 9-3: MIS: Urological and Gynecological Market Analysis: 2011-2015 Figure 9-2: MIS: Urological and Gynecological Market Analysis: 2008-2015 Table 9-4: MIS: Urological and Gynecological Market Analysis by Region/Country, 2010 Figure 9-3: MIS: Urological and Gynecological Market Analysis by Region/Country, 2010 Table 9-5: Leading MIS Urological and Gynecological Instrument and Equipment Suppliers, 2010CHAPTER TEN: TOTAL MARKET SIZE AND FORECAST Table 10-1: MIS: Total Market Analysis, 2008-2010 Table 10-2: MIS: Total Market Analysis: 2011-2015 Figure 10-1: MIS: Total Market Analysis: 2008-2015 Table 10-3: Minimally Invasive Surgery Market Analysis by Application, 2008- 2010 Table 10-4: Minimally Invasive Surgery Market Analysis by Application, 2011- 2015 Figure 10-2: Minimally Invasive Surgery Market Analysis by Application, 2008- 2015 Figure 10-3: Minimally Invasive Surgery Market Share by Application, 2010 Figure 10-4: Minimally Invasive Surgery Market Share by Application, 2015 Table 10-5: MIS: U.S. Market Analysis by Segment, 2010 Figure 10-5: MIS: U.S. Market Analysis by Segment, 2010 Table 10-6: MIS: Europe Market Analysis by Segment, 2010 Figure 10-6: MIS: Europe Market Analysis by Segment, 2010 Table 10-7: MIS: Rest of World Market Analysis by Segment, 2010 Figure 10-7: MIS: Rest of World Market Analysis by Segment, 2010 Table 10-8: Total Minimally Invasive Surgery Market Estimated Revenues and Market Share of Leading Suppliers 2010
  13. 13. Figure 10-8: Total Minimally Invasive Surgery Estimated Market Share by Leading Suppliers 2010CORPORATE PROFILES Figure 11-1: Aesculap’s Net Revenues for 2009 and 2010 Figure 11-2: ArthroCare Revenues and R&D Spending for 2009 and 2010 Figure 11-3: Boston Scientific’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-4: Conmed’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-5: Covidien’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-6: Given Imaging’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-7: Given Imaging’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-8: Johnson & Johnson and Ethicon Endo-Surgery’s Net Revenues and Johnson & Johnson’s R&D Expenses for 2009 and 2010 Figure 11-9: Medtronic’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-10: Olympus’ Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-11: Smith & Nephew’s Net Revenues and R&D Expenses for 2009 and 2010 Figure 11-12: Stryker’s Net Revenues and R&D Expenses for 2009 and 2010Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=6282643   US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004 

×